Early Detection of breast cancer Anthony B. Miller, MD, FRCP Associate Director, Research, Dalla Lana School of Public Health, University of Toronto, Canada.

Slides:



Advertisements
Similar presentations
Evidence-based Public Health Interventions Robert S. Lawrence, MD Bloomberg School of Public Health Johns Hopkins University April 20, 2005.
Advertisements

Breast Cancer Early Detection is Your Best Protection
†Source: U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2011 Incidence and Mortality Web-based Report. Atlanta (GA): Department.
ATLAS Steering Committee: 24 September 2005 Steering Committee meeting, 24 th September 2005 University of Oxford Examination Schools.
Screening Mammography: Regret or no regret? Joint Hospital Surgical Grand Round 19 May 2007 Yvonne Tsang Prince of Wales Hospital.
Somaiya Medical College and Maina Foundation Five Year Project for Raising breast Cancer Awareness in Pratikshanagar - Mumbai.
What is the evidence of benefits of PSA screening for prostate cancer? Outpatient Medicine.
ACCP Evidence base: Implications for policy and practice R. Sankaranarayanan MD Head, Screening Group World Health Organization (WHO) International Agency.
Linking Multilevel Analysis to Health Policy Interventions Richard B. Warnecke, Sarah Gehlert, Carol Ferrans, Richard Barrett, Julie Darnell, Young Cho,
Boston 1.
Breast Imaging Made Brief and Simple
299. Breast Cancer Screening Paul Jones, PGY2 Resident Rounds 25 July 2012.
PROJECT Situation analysis and cost- effectiveness analysis of cervical cancer screening in Russia Coordinator of the project: N. Koroleva.
Breast Cancer screening in the NHS Dr D J Rohan Subasinghe.
1 Knowledge, beliefs & information needs of Iranian Immigrant Women in Toronto regarding Breast Cancer and Screening Dr. Mandana Vahabi Associate Professor,
Knowledge, Cancer Fatalism and Spirituality as Predictors of Breast Cancer Screening Practices for African American and Caucasian Women Staci T. Anderson,
Nannozi Ssenkoloto, Program Manager October 8, 2013.
Breast cancer screening Mammography is the most widely used screening modality, with solid evidence of benefit for women aged 40 to 74 years Clinical breast.
Mammography Screening Information for Providers Indian Health Service National GPRA Team.
AIMGP Seminar Series January 2004 Joo-Meng Soh Edited by Gloria Rambaldini CANCER SCREENING PART II.
HSB examples from Finland Nea Malila Mass Screening Registry, Cancer Society of Finland and University of Tampere, Tampere School of Public Health.
Outcomes of screening mammography among women aged 40 to 43 Institute for Clinical Evaluative Sciences Toronto, Canada (2006)
Health Care Reform Through the Cancer Lens State and Private Sector Reforms for Hispanic Healthcare Edward E. Partridge, MD National Board President American.
EPIB-591 Screening Jean-François Boivin 29 September
Canadian Task Force on Preventive Health Care:
Cancer Care Ontario A Organizational Overview S Orientation Workshop July 16, 2014 Sheila M Densham, BA, TEACH Health Promotion Coordinator.
Breast cancer screening Diana Sarfati Director, Cancer Control and Screening Research Group.
Chapter 1. Chapter 2 Dr Spock 1956 edition switches his recommendation to face down USA Second study Suggests harm First.
An Integrated Approach to Breast Cancer Control A flexible approach that can be adapted to national or local circumstances.
Breast Cancer in Ghana How are we going to ‘beat’ it? Prof J-N Clegg-Lamptey SAMF Launch.
EFFICACY OF A STAGE-BASED BEHAVIORAL INTERVENTION TO PROMOTE STI SCREENING IN YOUNG WOMEN: A RANDOMIZED CONTROLLED TRIAL Chacko MR, Wiemann CM, Kozinetz.
 Volunteer bias  Lead time bias  Length bias  Stage migration bias  Pseudodisease.
Effect of community-wide isoniazid preventive therapy on tuberculosis among South African gold miners “Thibelo TB” Aurum Health Research LSHTM JHU Gold.
Breast Cancer in the Women’s Health Initiative Trial of Estrogen Plus Progestin For the WHI Investigators Rowan T Chlebowski, MD., Ph.D.
Incorporating Multiple Evidence Sources for the Assessment of Breast Cancer Policies and Practices J. Jackson-Thompson, Gentry White, Missouri Cancer Registry,
BREAST CANCER: Half a million women later… Amy Miglani M.D September 3, 2004.
Effect of process indicators on the episode sensitivity of mammography Tytti Sarkeala, MSc Finnish Cancer Registry Ahti Anttila Matti Hakama Irma Saarenmaa.
Senior Statistician Per-Henrik Zahl, MA MD PhD
Medicaid and the 4 A’s: Use of 1115 Waivers and State Plan Amendments American Cancer Society Washington, Dc June 5, 2008 Erin Reidy
Chronic diseases as tracer conditions in international benchmarking of health systems: the example of diabetes 1 European Centre on Health of Societies.
Kathleen Decker Alain Demers Daniel Chateau Marion Harrison Cervical Cancer in Manitoba: evaluating risk, Pap test utilization, and access CancerCare Manitoba.
Screening for oral cancer: Experience in developing countries
BC Cancer Agency CARE & RESEARCH Breast Cancer Mortality After Screening Mammography in British Columbia Women Andrew J. Coldman, Ph.D. Norm Phillips,
Colorectal Cancer Screening Implementation of a public health programme An Expert Group on Colorectal Cancer Screening Cancer Society of Finland, Finnish.
Mammographic screening Is it relevant to developing countries?
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
Appendix 2 Comparison of screening from age 20 and age 25 Table of harms and benefits.
Collaboration with Community Partners to Provide Breast and Cervical Cancer Services to the Underserved University of Texas Health Sciences Center at Tyler.
Evaluation of the Community Patient Navigation Program within the Community Education and Outreach Initiative (CEOI) Patient Navigation is one strategy.
COLLABORATION WITH COMMUNITY PARTNERS TO PROVIDE BREAST AND CERVICAL CANCER SERVICES TO THE UNDERSERVED Patti Olusola, M.D. 1, Sarah Low, M.D. 1, Michelle.
Lower Mammography Use is Associated with the Geographic Clustering of Late-stage Breast Cancer in Saint Louis City Min Lian, Donna B. Jeffe, Mario Schootman.
ELIGIBILITY CRITERIA- Summarised
Cancer prevention and early detection
Cancer prevention and early detection
Cancer prevention and early detection
TMIST A Breast Cancer Screening Trial
Quality issues in monitoring diagnostic and treatment performance Dr
Cancer prevention and early detection
Colorectal Cancer Screening Guidelines
Cancer prevention and early detection
University of Rajarata.
Population-Based Breast Cancer Screening With Risk-Based and Universal Mammography Screening Compared With Clinical Breast Examination A Propensity Score.
Mammograms and Breast Exams: When to start /stop mammograms
Overview of the performance indicators recommended by European guidelines for quality assurance in cervical cancer screening Dr. Rasa Vansevičiūtė, Lithuania.
Cancer prevention and early detection
Background & Objectives
Definition of Cancer Screening
Kathleen England Neville Calleja 20th October 2017
Physical Activity and Endometrial Cancer Survival
Challenges in Evaluating Screening & Prevention Interventions
Presentation transcript:

Early Detection of breast cancer Anthony B. Miller, MD, FRCP Associate Director, Research, Dalla Lana School of Public Health, University of Toronto, Canada

The problem  In low and middle income countries, breast cancer is usually diagnosed at an advanced stage  The majority of breast cancers are diagnosed in women under the age of 50  Mammography screening is less effective in women under age 50, and the technical and personnel requirements for population- based mammography screening are very substantial.

Early detection  Public education  Professional education  Breast self examination  Clinical breast examination  Mammography

Two linked broad strategies  Early diagnosis of symptomatic women  Screening of asymptomatic women

Prerequisites for both strategies  Adequate facilities for diagnosis  Effective, accessible, affordable, treatment

Requirements for effective screening  An informed decision to initiate or re- organize screening in the context of a National Cancer Control Programme  The political will to proceed  Support and funding from the Ministry of Health  An adequate health care infrastructure  Trained and informed managers

IARC Working Group, 2002 Reduction in risk of death from breast cancer by mammography screening:  Women aged 40–49: 12%  Women aged 50–69: 25%

The UK trial of mammography among women age  160,921 women randomized, 1: 2, intervention : control  Mammography annually for 7 years in intervention arm  All women enter UK screening program at age 50

The UK trial of mammography among women age Ratio of breast cancer deaths at mean follow-up of 10.7 years in intervention arm relative to the control: 0.83 (95% CI )

Review for US Preventive Services Task Force (Nelson et al, 2009) Relative risk of breast cancer death, mammography vs. no screening, for women age 40-49: 0.85 (95% CI )

IARC Working Group, 2002 There is inadequate evidence for the efficacy of screening women by clinical breast examination in reducing mortality from breast cancer. There is inadequate evidence for the efficacy of screening women by breast self-examination in reducing mortality from breast cancer.

Canadian National Breast Screening Study (CNBSS)-2 n 39,405 women age randomized to: u Annual two-view mammography + physical examination (CBE) + BSE (MP) u Annual physical examination (CBE) + BSE only (PO) n 5 or 4 screens and years follow-up

Occurrence of Invasive Breast Cancers in CNBSS-2 MP PO Screen detected Interval cancers Incident cancers Total [Total in situ 71 16]

CNBSS-2 Deaths from breast cancer, years follow-up MPPO Women years (10 3 ) Breast cancer deaths Rate/10, Rate ratio (95% CI) 1.02 (0.78, 1.33)

Model based analysis of CNBSS 2 (Rijnsberger et al, 2005) In comparison to no screening, as in the control group of the Swedish Two-county trial, the breast examinations resulted in a 20% reduction in breast cancer mortality.

Explanations for trends  Timing of recent fall compatible with improvements in therapy  Timing and lack of effect in some countries is not compatible with an effect of mammography screening  Lack of fall prior to 1990 suggests that early detection is not effective in the absence of effective treatment

Community program in Sarawak, Malaysia (Devi et al, 2007)  Community nurses trained  BSE taught  CBE offered Breast cancers presenting at late stage (III & IV) u 77% in 1993 u 37% in 1998

The Cairo Breast Screening Trial (Boulos et al, 2005) 1.To determine whether breast examinations combined with the teaching of breast self- examination (CBE+BSE), performed by trained health professionals, reduces the cumulative incidence of advanced (stage 3 or worse) breast cancer. 2.To determine whether CBE+BSE reduces mortality from breast cancer.

Criteria of Eligibility  Women age  No personal history of breast cancer,  Resident in the study area,  Not enrolled in any other breast screening program  Consent has been obtained

Reasons for starting at age 40  The incidence of breast cancer is lower in women age than  More women age have to be examined to find a case of breast cancer than women age 40-44

Breast cancer incidence rates (per 100,000) Age CanadaEgypt Casablanca

Number of women to be examined, to find one case of breast cancer Age CanadaEgypt Casablanca

Recruitment and registration Areas were identified with easy access to the designated breast diagnosis centre. Visits were performed by trained social workers to every home in a systematic manner, aided by maps. Women age were identified and interviewed using a breast cancer risk factor questionnaire. Health information on breast cancer was provided. They were told where to attend if they have a problem with their breasts.

Randomisation (after Pilot study) Group (cluster) - defined by sub-area (social worker). All women randomized to screening were invited to attend the designated primary health centre, staffed by young female doctors, carefully trained in CBE+BSE.

Process for screening and diagnosis CBE performed and BSE taught at PHC Those deemed abnormal referred to the diagnosis centre At diagnosis centre, women re-examined by study surgeon Those confirmed abnormal receive mammography, and if needed ultrasound and FNA

Compliance, screened group Number contacted Attended PHC Number abnormal % diagnosed Pilot – Area %29182 Randomized year %6383 Area %88 Re-screening %5693 Area %11478

Breast Cancer Detection (per 1,000) ScreenControl Pilot8.2- Randomized Area Re-screening Area

Stage of detected cancers StagePilot componentRandomized component All screenedScreenedControl NumberPercentNumberPercentNumberPercent I II III IV Total

The Mumbai Breast Screening Trial (Mittra et al, 2009) ScreeningControl Number of women75,36076,178 Compliance91%, 87%, 88% Diagnosis compliance68%, 71%, 78% Breast cancers detected Interval cancers Total: early stage7838 advanced stage4749 Breast cancer deaths2210

Conclusions  Mammography screening may not be superior to early diagnosis plus adequate treatment  Alternative approaches to screening are being evaluated in a number of LMIC settings  We are beginning to collect good data on effectiveness  Such research should continue and be expanded